Claims
- 1. A vaccine against bovine respiratory disease comprising:
- (a) an effective immunological system triggering concentration of live organisms having capsular antigens selected from the group consisting of a strain of ATCC #53839 and a strain of ATCC #53840; and
- (b) a carrier.
- 2. A vaccine composition comprising an attenuated strain of Pasteurella haemolytica having the identifying characteristics of ATCC #53839.
- 3. A vaccine according to claim 2 further comprising a pharmaceutically acceptable diluent.
- 4. A vaccine composition comprising an attenuated strain of Pasteurella haemolytica having the identifying characteristics of ATCC #53840.
- 5. A vaccine according to claim 4 further comprising a pharmaceutically acceptable diluent.
- 6. A process for vaccinating an animal against Pasteurella haemolytica, biotype A, serotype 1 comprising the step of presenting an effective immunological system triggering culture of live organisms having capsulator antigens of Pasteurella haemolytica, biotype A, serotype 1, to said animal's immunological system wherein said culture is derived from the group consisting of a strain of ATCC #53839 and a strain of ATCC #53840.
Parent Case Info
This is a continuation of copending application Ser. No. 07/325,866 filed on Mar. 20, 1989, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4346074 |
Gilmour et al. |
Aug 1982 |
|
4957739 |
Berger et al. |
Sep 1990 |
|
Non-Patent Literature Citations (1)
Entry |
Squire et al, Infection and Immunity, vol. 45, No. 3, pp. 667-673, 1984. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
325866 |
Mar 1989 |
|